Psyence Biomedical Ltd.
PBM • Biotechnology
$4.54
▲ +0.11 (+2.48%)
Current price
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$6.73M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Reasonable earnings multiple · 14.15Manageable debt level · 0Healthy liquidity · 11.04Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Sep 30, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.54
Change2.48%
Shares Out1.48M
Market Cap$6.73M
Enterprise Value$-471.04K
Beta1.65
P/E-0.26
P/B0.57
P/FCF-6.38
EV/EBITDA0.22
EV/FCF0.45
Earnings Yield-390.30%
Price$4.54
Change2.48%
Shares Out1.48M
Market Cap$6.73M
Enterprise Value$-471.04K
Beta1.65
P/E-0.26
P/B0.57
P/FCF-6.38
EV/EBITDA0.22
EV/FCF0.45
Earnings Yield-390.30%
FCF Yield-15.67%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio11.04
Quick Ratio11.04
Volume35.02K
Avg Volume2.62M
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
85/100
Why this score▼
Reasonable earnings multiple · 14.15Manageable debt level · 0Healthy liquidity · 11.04Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.